lansoprazole has been researched along with Animal Mammary Carcinoma in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lansoprazole was not toxic to cancer cells but potentiated the cytotoxicity of doxorubicin and enhanced its penetration through multilayered cell cultures." | 1.42 | Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors. ( Lee, C; Tannock, IF; Wang, M; Yu, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, M | 1 |
| Lee, C | 1 |
| Wang, M | 1 |
| Tannock, IF | 1 |
1 other study available for lansoprazole and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors.
Topics: Animals; Antibiotics, Antineoplastic; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Cell Pr | 2015 |